(image) Substance Abuse and Mental Health Services Administration Skip To Content
(image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration
(image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration (image) Substance Abuse and Mental Health Services Administration
Quick Search
Financing Center of Excellence

Search

 
 
What are you looking for?
Welcome to the Financing Center of Excellence Guided Search. To easily locate information on our website, enter a keyword into the “Key Term” search box. If you would like to narrow your search further, you can include or exclude Topics or Categories filters. To add filters, click “Add another category or topic” and select a Topic/Category. There is no limit to the number of Topics/Categories that you can use to filter results.

Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Medicare Beneficiaries 2005 to 2009
"On August 25, AARP released a report examining retail prices for brand name prescription drugs between 2005 and 2009.  The report found that the cost of the most popular drugs rose 41.5 percent ..."
Topics : Access/Barriers, Cost-effectiveness, Prescription Drugs, Rates/Reimbursement, Seniors, Spending, Treatment
Categories : Special Populations, Medicare, Treatment and Recovery



Savings Achieved through the Use of Generic Pharmaceuticals
"A report released by the Generic Pharmaceutical Association (GPhA) found that a 2 percent increase in the substitution of generic drugs for identical brand name products would yield a $1 billion sav ..."
Topics : Cost-effectiveness, Medicaid, Prescription Drugs, Quality , Treatment
Categories : Treatment and Recovery, Medicaid



US Pharmaceutical Innovation in an International Context
"A study in the June issue of the American Journal of Public Health found that the higher prices U.S. consumers pay for brand name prescription drugs do not result in higher rates of new drug develop ..."
Topics : Cost-effectiveness, Prescription Drugs, Rates/Reimbursement, Spending, Treatment
Categories : Treatment and Recovery



Prescription Drug Accessibility and Affordability in the United States and Abroad
"On June 1, the Commonwealth Fund released a brief examining prescription drug access, affordability, and cost in the U.S. and six other high-income countries.  The brief notes that Americans ar ..."
Topics : Access/Barriers, Cost-effectiveness, Prescription Drugs, Quality , Regulation, Spending
Categories : Legislative and Regulatory Issues, Treatment and Recovery, Special Populations



Geographic Variation in Medicare Drug Spending
"The New England Journal of Medicine (NEJM) published a study examining Medicare Part D prescription drug spending by region.  The study found significant regional variance that was not offset b ..."
Topics : Medicare, Prescription Drugs, Spending, State Data
Categories : Special Populations, Medicare, Treatment and Recovery



Entering and Exiting the Medicare Part D Coverage Gap: Role of Comorbidities and Demographics
"Examining Medicare enrollees in eight states, a study published in the Journal of General Internal Medicine isolated certain factors associated with increased entrance into Medicare’s prescrip ..."
Topics : Access/Barriers, Medicare, Mental Health, Prescription Drugs, Treatment
Categories : Medicare, Special Populations, Treatment and Recovery, Mental Health



IMS Health Report Finds Prescription Drug Sales Are Up, Anti-Psychotics Top Sellers
"On April 1, IMS Health released a report finding that prescription drug sales grew 5.1 percent from 2008 to 2009, totaling $300.3 billion.  By sales, antipsychotic medications were the top sell ..."
Topics : Mental Health, Prescription Drugs, Providers, Spending, Treatment
Categories : Treatment and Recovery, Mental Health



Mathematica Brief Examines Nursing Care For Dual Eligibles, Recommends Transferring Responsibility to Medicare
"This Mathematica Policy Research Inc. brief examines avenues for reducing the fragmentation of care for dual eligibles in nursing homes.  The brief suggest shifting the responsibility for such ..."
Topics : Dual Eligibles, Medicaid, Medicare, Prescription Drugs, Providers, Spending, Treatment
Categories : Medicaid, Medicare, Special Populations, Treatment and Recovery



Therapies to Better Manage Depression Provide Cost Savings for Employers
"This Thomson Reuters  study funded by Sanofi Aventis and published in the Journal of Occupational and Environmental Medicine found that, even when treated with antidepressants, depressed worker ..."
Topics : Cost-effectiveness, Mental Health, Prescription Drugs, Quality , Spending, Treatment
Categories : Mental Health, Treatment and Recovery



Unforeseen Benefits: Addiction Treatment Reduces Health Care Costs
"This report from the Open Society finds that addiction treatment reduces overal health care costs.  From the executive summary: Addiction is a pervasive yet treatable chronic health ..."
Topics : Cost-effectiveness, Prescription Drugs, Substance Abuse, Treatment
Categories : Treatment and Recovery, Substance Abuse



Impact of the STAR*D Trial From the Perspective of the Payer
"This article discusses the implications of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial for private and public payers.  The STAR*D trial found that, for second- and ..."
Topics : Mental Health, Prescription Drugs, Quality , Treatment
Categories : Mental Health, Treatment and Recovery



Iowa Releases 2010 Drug Control Strategy
"The Iowa Office of Drug Control Policy, the Drug Policy Advisory Council, and the state Departments of Corrections; Education; Human Rights, Criminal and Juvenile Justice Planning; Human Services; P ..."
Topics : Criminal/ Juvenile Justice, Illegal Drugs, Prescription Drugs, Prevention, Spending, State Data, Substance Abuse, Treatment
Categories : State and Local, Treatment and Recovery, Prevention and Wellness, Substance Abuse



General Medical and Pharmacy Claims Expenditures in Users of Behavioral Health Services
"This study aims to quantify the amount of medical and pharmacy claim expenditures to individuals using M/SU services and assess future claims.  The study found that 10.7 percent of enrollees ha ..."
Topics : Mental Health, Prescription Drugs, Spending, Treatment
Categories : Mental Health, Treatment and Recovery, Substance Abuse



A Cost-Effectiveness and Cost-Benefit Analysis of Contingency Contracting-Enhanced Methadone Detoxification Treatment
"This study examined methadone treatment with and without contingency contracting, which provides reinforcement for negative drug and alcohol tests through the treatment process.  The study foun ..."
Topics : Alcohol, Cost-effectiveness, Illegal Drugs, Prescription Drugs, Spending, Substance Abuse, Treatment
Categories : Treatment and Recovery, Substance Abuse



Cost-Benefit Analysis of Drug Treatment Services: Review of the Literature
"This article reviews the substance abuse treatment cost-benefit literature. The review found that benefits exceeded costs in all 18 studies, even when not all benefits were accou ..."
Topics : Cost-effectiveness, Prescription Drugs, Rates/Reimbursement, Substance Abuse, Treatment
Categories : Treatment and Recovery, Substance Abuse



Persisting Decline in Depression Treatment After FDA Warnings
"This study of depression treatment in the wake of FDA warnings regarding suicide in children taking antidepressants found that the frequency of depression diagnoses decreased and cont ..."
Topics : Children & Adolescents, Mental Health, Prescription Drugs, Regulation, Treatment
Categories : Mental Health, Special Populations, Treatment and Recovery, Legislative and Regulatory Issues



Trends in Antidepressant Utilization from 2001 to 2004
"This study found that, after years of increased use of antidepressants, a trend reversal began in the early 2000s which included decreasing rates of adequate antidepressant treatment. &nbs ..."
Topics : Mental Health, Prescription Drugs, Spending, Treatment
Categories : Mental Health, Treatment and Recovery



Pediatric Antidepressant Use After the Black-Box Warning
"This study found that, after the FDA required a black-box warning on antidepressants outlining the possible suicide risk in children, antidepressant use declined sharply over all age groups--includi ..."
Topics : Children & Adolescents, Mental Health, Prescription Drugs, Treatment
Categories : Mental Health, Special Populations, Treatment and Recovery



Association of Antipsychotic Use with Hospital Events and Mortality Among Medicare Beneficiaries Residing in Long-Term Care Facilities
"This study found no evidence that use of antipsychotic medication in long-term care facilities was associated with increased hospital events or mortality.    Simoni-Wastila ..."
Topics : Medicare, Mental Health, Prescription Drugs, Providers, Quality , Treatment
Categories : Medicare, Mental Health, Treatment and Recovery



Prior Authorization for Antidepressants in Medicaid: Effects Among Disabled Dual Enrollees
"This article examines the use of a controversial prior authorization policy in the Michigan Medicaid program on antidepressant use and and health outcomes for dually eligible Medicaid and Medicare e ..."
Topics : Access/Barriers, Dual Eligibles, Medicaid, Medicare, Mental Health, Prescription Drugs, State Data, Treatment
Categories : Medicaid, Medicare, Mental Health, State and Local, Special Populations, Treatment and Recovery